Habituation's Mechanisms in Preterm and Term Infants (HABIPREMA)

February 7, 2023 updated by: University Hospital, Brest

Habituation's Mechanisms in Preterm and Term Infants. Behavioral Evaluation: APIB (Assessment of Preterm Infant's Behavior). Assessment of the Cortical and Vegetative Responses

Each year in France, 7 % of newborns are born preterm (before 37 weeks of gestational age (GA)). The investigators called very preterm infants those who were born before 33 weeks of GA. These very preterm infants have a higher risk of developing neurological complications like developmental disabilities or cerebral palsy. To date, early assessment of these infants is difficult and not reliable enough to detect those who are at risks of developing neurological issues. Now, the investigators need to identify earlier these infants to provide them interventions to improve their development (physical therapy for example). Consequently, the investigators are examining a study whose aim is to assess preterm infants habituation. Habituation is the newborn ability to become familiar with new environmental stimulations (noise, light…). This habituation allows the newborn to maintain his sleep even at onset of a noise or light. To study this phenomenon in infants born preterm near to corrected term (around 40 weeks of postnatal GA), will allow us to better understand neurological development of these infants. The investigators plan to compare habituation skills of preterm infants near to their theorical date of birth (40 weeks of GA) to a population of infants born at term. The investigators will also study the link between habituation abilities and sleep quality as well as neurodevelopmental outcome at the corrected age of two years old.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brest, France, 29609
        • Recruiting
        • CHRU de Brest

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 days to 2 months (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Preterm infants and term infants born in Brest University Hospital

Description

Inclusion Criteria:

  • Preterm infants: preterm infants born from 25 weeks to 32 weeks + 6 days of gestation near to 36 weeks of gestation (corrected postnatal age)
  • Term infants: term newborns with a gestational age between 39 and 41 weeks of gestation at day 3 with an Apgar ≥ 1 at 1 minute of life
  • For both groups: normal neurological physical examination, written informed consent of the parents

Exclusion Criteria:

  • no malformation or chromosomal abnormality, life threatening disease, administration of morphine or sedatives during the 24 hours before the study, context of maternal drug addiction, deafness, no psychoactive drug or anticonvulsivants during the last month of pregnancy for the term newborns, severe neurological disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Preterm infants
Preterm infants born between 25 weeks and 32 weeks + 6 days of gestation
Other Names:
  • Sound and light stimulations
Term newborns
Infant born at term
Other Names:
  • Sound and light stimulations

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Assessment of the package n°1 of the APIB (Assessment of Premature Infant's Behaviour)
Time Frame: At 40 weeks of postnatal gestational age for the preterm infants and at 3 days old for the term newborns
At 40 weeks of postnatal gestational age for the preterm infants and at 3 days old for the term newborns

Secondary Outcome Measures

Outcome Measure
Time Frame
Salivary cortisol changes
Time Frame: Before and 30 minutes after the package n°1 of the APIB achievement
Before and 30 minutes after the package n°1 of the APIB achievement
Oxy and deoxyhemoglobin changes in NIRS (Near-infrared Spectroscopy)
Time Frame: During APIB package n°1 fulfillment
During APIB package n°1 fulfillment
Heart rate variations
Time Frame: During APIB package n°1 fulfillment
During APIB package n°1 fulfillment
Oxymetry variations
Time Frame: During APIB package n°1 fulfillment
During APIB package n°1 fulfillment
Brief Infant Sleep Questionnaire
Time Frame: At 6 and 12 months old (corrected age for the preterm infants)
At 6 and 12 months old (corrected age for the preterm infants)
Ages and Stages Questionnaire
Time Frame: At 24 months old (corrected age for the preterm infants)
At 24 months old (corrected age for the preterm infants)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 9, 2015

Primary Completion (ANTICIPATED)

July 1, 2026

Study Completion (ANTICIPATED)

July 1, 2026

Study Registration Dates

First Submitted

July 9, 2015

First Submitted That Met QC Criteria

July 13, 2015

First Posted (ESTIMATE)

July 14, 2015

Study Record Updates

Last Update Posted (ESTIMATE)

February 9, 2023

Last Update Submitted That Met QC Criteria

February 7, 2023

Last Verified

February 1, 2023

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Habituation, Psychophysiological

Clinical Trials on Package n°1 of the APIB

3
Subscribe